Missouri's cannabis regulator is telling licensees that federal Schedule III registration adds requirements on top of state law, not in place of it. But Missouri's 209 applications for expedited DEA registration remain unregistered, and the agency has not answered whether the state's comprehensive licenses, which cover both medical and adult-use cannabis, qualify. A proposed denial involving a similar dual-purpose license in Minnesota adds another complication as the DEA's November 29 supply-chain date in its nonbinding guidance approaches.
Missouri cannabis operators are caught between two regulatory systems. In guidance dated November 2, 2026, the Missouri Department of Health and Senior Services clarified that federal Schedule III registration does not replace the state's cannabis framework and that interstate commerce remains prohibited until Missouri updates its own rules. Meanwhile, Missouri has 209 entries on the DEA's timely-applicant list still waiting, none included among the DEA's initial approvals, and the central question remains unanswered: does a Missouri comprehensive license covering both medical and adult-use cannabis qualify as a federal state medical license?
Missouri's Message: Federal Registration Does Not Replace State Law
The Missouri Department of Health and Senior Services' Division of Cannabis Regulation published its document, titled "Federal Rescheduling — Guidance Document," on November 2, 2026. The guidance received fresh industry coverage on November 9.
Its central message is that federal rescheduling creates an additional layer of compliance rather than replacing Missouri's existing medical cannabis regulations.
The document states:
"The recent federal rescheduling of state licensed medical marijuana does not replace Missouri's medical marijuana regulatory program. Instead, it adds federal requirements on top of the existing state framework, creating a dual layer system in which licensees must comply with both Missouri regulations and applicable federal obligations, if the licensee chooses to register with the DEA."
The guidance repeatedly frames DEA registration as the licensee's choice as a matter of state compliance.
It also explains the relationship between state licensing and federal registration:
"Under the Department of Justice's Final Order, DEA registration now functions as the formal link between Missouri's state regulatory structure and federal controlled substance law."
Missouri operators must continue following their existing state requirements regardless of whether they pursue federal registration.
"Missouri licensees must continue operating exactly as they do today under state authority. Federal registration is dependent on maintaining state licensure."
The underlying federal final rule was published April 28, 2026, at 91 FR 22714.
Interstate Commerce Is Still Off-Limits
One of the clearest instructions in the Missouri guidance concerns importing and exporting cannabis.
The department states:
"Missouri law currently does not authorize import, export, or interstate commerce of regulated cannabis. While licensees may receive such authorization via the federal registration process, exercising that authority will not be possible until Missouri updates its rules and infrastructure to align with federal changes."
The guidance warns that these activities would constitute Diversion or Inversion under Missouri law.
It also says:
"DHSS will issue further guidance when rules and infrastructure are updated to operationalize any federal changes in this area, if applicable."
The document closes by instructing licensees to avoid importing, exporting or engaging in interstate cannabis commerce until Missouri's rules are updated.
Federal registration therefore does not independently give Missouri businesses permission to move regulated cannabis across state lines.
209 Missouri Applications Are Still Waiting
The registration question affects a substantial group of Missouri cannabis businesses.
According to DEA application data reported by Marijuana Moment and Cannabis Business Times, Missouri accounts for 209 entries on the DEA's timely-applicant list from the agency's expedited application window, which ran from April 28 through June 26, 2026. The list counts applications by activity, not distinct businesses.
The applicants included:
- 156 dispensaries - 18 distributors - 35 manufacturers
None appeared among the first group of DEA registrations issued on October 30.
Those initial registrations went to dispensaries in seven states with medical-only licensed retail markets: Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia — including Virginia, where adult-use retail sales have not yet begun.
The DEA list still showed 209 Missouri entries as of November 9.
The DEA's October 30 guidance says timely applicants are expected to verify their trading partners and establish compliant supply chains no later than November 29, 2026. The document is nonbinding and expressly states that it does not have the force and effect of law. It also provides a limited existing-inventory exception for timely dispensary and distributor applicants, but does not expressly extend that exception to manufacturers.
That date does not appear in Missouri's November 2 guidance, but it remains an important one for the applicants waiting on federal registration.
Does a Missouri Comprehensive License Qualify?
The biggest unanswered question concerns Missouri's comprehensive cannabis licenses.
Following Amendment 3 in 2022, Missouri facilities converted to comprehensive licenses covering both medical and adult-use operations.
The federal rule created new Schedule III categories for marijuana, extracts and naturally derived delta-9 THC subject to qualifying state medical marijuana licenses. Whether Missouri's comprehensive licenses meet that federal definition remains unresolved.
The Division of Cannabis Regulation previously addressed the issue in a May 6, 2026 email to licensees, reported by MJBizDaily in September.
The department said registration was:
"not a requirement at this time to remain in compliance with DCR"
It also stated:
"it will be up to DEA to decide if a license type that serves both medical and adult-use populations is eligible for DEA registration"
The department added:
"At this time, DCR does not have a pathway to convert a comprehensive license to a medical marijuana license."
The November 2 guidance does not resolve the question or establish a pathway for comprehensive licensees to obtain separate medical licenses.
That leaves Missouri businesses waiting for the DEA to determine whether their existing license structure meets the federal requirements.
Minnesota Shows What a Federal Denial Could Look Like
Missouri's uncertainty has a relevant comparison in Minnesota.
On October 30, 2026, reporting revealed that the DEA had issued an Order to Show Cause to In-Dispensary, LLC, a Minneapolis operator, proposing to deny its registration.
The agency's position is that Minnesota's dual-purpose license does not qualify as a state medical license under the federal framework and does not provide what the DEA describes as "robust" protections against diversion.
The proposed denial is not a final decision. The company can request a hearing and propose a corrective action plan.
Legal analysis of the order has also noted that two of the DEA's three grounds for the proposed denial are specific to Minnesota.
Nevertheless, the proceeding illustrates the question facing Missouri's comprehensive-license holders: a license covering both medical and adult-use cannabis may not automatically satisfy the federal definition of a state medical license.
No Missouri applicant has been reported denied on this basis.
MoCannTrade Members Mostly Took a Wait-and-See Approach
Not every Missouri cannabis business pursued federal registration.
According to MJBizDaily's September 22 reporting, approximately one-third of the Missouri Cannabis Trade Association's more than 90 members had applied for DEA registration, Executive Director Andrew Mullins said.
None had been approved as of mid-September.
One factor behind the cautious approach is the size of Missouri's medical market. Medical cannabis represented less than 9% of total marijuana sales, according to Division of Cannabis Regulation data.
For many operators, the potential benefits of federal registration had to be weighed against the uncertainty surrounding eligibility and compliance.
Mullins emphasized that businesses seeking the advantages of Schedule III needed to have applied during the original 60-day window.
The market itself is substantial. A state-commissioned study published in October identified 222 comprehensive dispensary licenses and five microbusiness dispensary licenses approved to operate as of July 22, 2026, while Missouri dispensary sales reached approximately $1.51 billion in 2025.
The Rules That Still Apply Inside Missouri
While federal registration remains unresolved for many operators, the November 2 guidance confirms that existing Missouri requirements continue.
Licensees must maintain:
- Metrc track-and-trace compliance. - Missouri's existing cannabis testing standards. - Current state licensing requirements. - Existing visitor procedures for regulatory inspections.
The department also explains that DEA agents may enter licensed facilities for inspections, audits or diversion investigations. These visits must be treated as official regulatory visits under Missouri's existing visitor rules.
Additional confidentiality provisions under HB 2641 are scheduled to take effect November 11, 2026.
The guidance does not change Missouri's existing operating framework while federal registration proceeds.
November 29 Is Approaching, but the Main Question Remains Open
Missouri's November 2 guidance establishes one clear position: state law remains in force, and interstate commerce cannot begin until Missouri updates its own rules and infrastructure. Missouri does not require DEA registration as a condition of maintaining a state cannabis license. However, federal law separately governs registration requirements for handling Schedule III medical marijuana. The distinction between state licensing compliance and federal authorization is central to the uncertainty facing Missouri operators.
But it leaves the most consequential eligibility question unanswered.
The 209 Missouri applications for expedited DEA registration are still waiting, and the agency has not clarified whether Missouri's comprehensive licenses qualify as federal state medical licenses.
The proposed Minnesota denial provides a warning about how the DEA may interpret dual-purpose licenses, but it does not establish the outcome for Missouri.
With November 29 approaching, Missouri operators face a federal registration process whose requirements are still being worked out while their existing state obligations remain unchanged.
Sources
- Missouri Department of Health and Senior Services, Division of Cannabis Regulation. “Federal Rescheduling — Guidance Document.” November 2, 2026. Link
- Cannabis Business Times. “Missouri Issues Cannabis Rescheduling Guidelines, Warns Licensees to Follow State Law.” November 9, 2026.
- Marijuana Moment. “Missouri Officials Warn Marijuana Businesses That Interstate Commerce Is Not Allowed, Even Under Federal Rescheduling.” November 9, 2026; and DEA timely-applicant list state table.
- MJBizDaily. “Most Missouri Cannabis Operators Opted Out of DEA Registration. Was It a Mistake?” September 22, 2026.
- U.S. Department of Justice / DEA. First Schedule III registrations announcement and Timely Applicant guidance. October 30, 2026.
0 comments